Skip to content

Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study

Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02902406
Enrollment
300
Registered
2016-09-15
Start date
2016-04-18
Completion date
Unknown
Last updated
2018-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer

Brief summary

This is a follow up study which aims to evaluate the correlation between several methylated genes (potential biomarkers) and oral cancers. A prospective case control trial is designed with sample size of at least 300 cases with estimated 200 subjects with precancerous lesion or oral cancer, and 100 subjects with normal oral mucosa. This study is approved by the National Taiwan University Hospital Research Ethics Committee. After signing the informed consent, all subjects will receive an intraoral examination and followed by epithelial cells collection with oral swab. The gDNA will be extracted from the oral swab collected cells and followed by bisulfite conversion procedures. Subsequently, bisulfite converted DNA will be subjected to methylated gene detection by Real-Time PCR. The methylation index (clinical sensitivity and specificity) of oral cancer related genes will be evaluated. For diagnosis confirmation, photos and biopsy specimens will be taken upon observation of abnormal lesion.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject with age over 20. * Subjects with oral mucosal findings (normal, oral mucosal lichen planus, precancerous lesion, and oral cancer) or subjects who have involved in the previous study (NCT01945697). * Subjects agrees to sign the informed consent form.

Exclusion criteria

* Pregnant woman. * Subject disagrees to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
DNA methylation2 years

Countries

Taiwan

Contacts

Primary ContactShih-Jung Cheng, PhD
sjcheng56@ntu.edu.tw886-2-23123456
Backup ContactHsiao-Shan Lin, MD
susan@istat.com.tw

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026